Breast cancer (BC) remains a major cause of cancer-related deaths, with less than 30% 5-year survival rate in patients with metastatic disease (https://www.acs.org/). Triple-negative BC (TNBC) presents a particularly difficult diagnosis with lack of targeted therapies. A better understanding of tumorigenesis- and metastasis-associated cellular adaptations could open novel approaches to improve the survival of metastatic BC patients.

EPS15-homology (EH) domain-containing (EHD) proteins (EHD1-4) are evolutionarily conserved lipid membrane-activated ATPases that regulate inward or outward vesicular traffic between the plasma membrane and intracellular organelles by controlling tubulation and scission of trafficking vesicles (Naslavsky and Caplan, 2011). Unlike other family members, which predominantly localize to endosomal and other intracellular compartments, EHD2 is known to primarily localizes to plasma membrane caveolae to maintain their stable membrane pool (Morén et al., 2012; Stoeber et al., 2012), suggesting a likely role in caveolae-associated cellular functions. Indeed, caveolae-dependent fatty acid uptake in adipocytes and eNOS-NO induced small blood vessel relaxation are impaired in Ehd2 knockout mice (Matthaeus et al., 2020; Matthaeus et al., 2019). EHD2-dependent stabilization of caveolae was also found to promote the cell surface expression of ATP-sensitive K⁺ channels and protect cardiomyocytes against ischemic injury (Yang et al., 2018). Caveolae are key to buffering the plasma membrane stress (Sinha et al., 2011) and EHD2 has been shown to positively regulate mechano-transduction through re-localization to the nucleus and regulation of gene transcription (Torrino et al., 2018).

Recent studies have painted a complex picture of the potential roles of EHD2 in cancer. Reduced EHD2 expression was reported in esophageal, colorectal, breast, and hepatocellular cancers (Li et al., 2013; Guan et al., 2021; Yang et al., 2015; Liu et al., 2016), with in vitro knockdown or overexpression studies supporting a tumor suppressive role for EHD2. On the contrary, EHD2 overexpression was found as a component of a mesenchymal signature in malignant gliomas with shorter survival, and knockdown analyses showed the EHD2 requirement for cell proliferation, migration, and invasion (Zhang et al., 2021). Higher EHD2 mRNA expression in papillary thyroid carcinomas was associated with extrathyroidal extension, lymph node metastasis, higher risk of recurrence, and presence of BRAF-V600E mutation (Kim et al., 2017). Studies of clear cell renal cell carcinoma also supported a positive role of EHD2 in tumorigenesis (Liu et al., 2019). A recent study provided a more mixed picture, with loss of EHD2 expression in TNBC cell lines enhancing their proliferation, migration, and invasion but low levels of EHD2 mRNA in TNBC patient tumors predicting better prognosis (Shen et al., 2020). Thus, a definitive role of EHD2 in oncogenesis and its mechanisms remain unclear.

Here, our comprehensive expression analyses in BC samples and in vitro and in vivo studies using EHD2 knockdown or knockout approaches in TNBC cell models provide definitive evidence for strong pro-tumorigenic and pro-metastatic role of EHD2. Our studies suggest a novel pro-oncogenic mechanism of EHD2, namely its requirement for efficient store-operated calcium entry (SOCE), a pathway known to promote tumorigenesis and metastasis in breast and other cancers (Mo and Yang, 2018; Yang et al., 2009).

Elucidating novel tumorigenesis- and metastasis-associated cellular adaptations could dictate new therapeutic options in BC. Here, we use TNBC cell models to elucidate a novel signaling axis linking EHD2 overexpression in BC to store-operated calcium entry (SOCE), a known pro-oncogenic and pro-metastatic pathway. Our studies support the potential for targeting the SOCE pathway in EHD2-overexpressing TNBC and other BC subtypes.

Our IHC analyses demonstrated high cytoplasmic EHD2 expression in a substantial proportion of breast tumors, associated with shorter BC-specific patient survival (Figure 3B) and higher tumor grade (Supplementary file 1-Table 1). A higher proportion of TNBC, luminal B and HER2 + patients exhibited high cytoplasmic EHD2 (Figure 3D, Supplementary file 1-Table 1). Our results differ from reports that reduction in EHD2 expression correlates with tumor progression in BC (Yang et al., 2015; Shi et al., 2015). Notably, a recent study, while it reported the depletion of EHD2 to increase the oncogenic traits of BC cell lines in vitro, found low EHD2 expression in breast tumors to specify good prognosis and better chemotherapy response (Shen et al., 2020). Several factors could account for the discordance, including the lack of validation of antibodies in prior studies, the high EHD2 expression in normal mammary adipocytes (Figure 1B), resulting in apparent reduction in EHD2 expression in tumor tissue using western blotting (Yang et al., 2015; Shen et al., 2020; Shi et al., 2015), and the possibility that EHD2 signals in prior studies represented nuclear EHD2, which we find is associated with positive prognostic factors (Figure 3B, Supplementary file 1-Table 1). Previous cell-line-based studies have shown that EHD2 shuttles between the nucleus and cytoplasm based on nuclear import and exit signals, the latter dependent on its SUMOylation, and that nuclear EHD2 repressed transcription from fused transactivation domains (Pekar et al., 2012). Another study found that application of mechanical stress to cells led to EHD2 release from caveolae, its SUMOylation and nuclear translocation where it regulated transcription of several genes including caveolar components, in a potential positive feedback mechanism (Torrino et al., 2018). However, no roles have thus far been assigned to the nuclear/cytoplasmic partitioning of EHD2 in oncogenesis. In view of the opposite prognostic significance of nuclear vs. non-nuclear EHD2 in our analyses of BC patient samples, it could be speculated that nuclear translocation may sequester EHD2 to inhibit its plasma membrane-associated pro-oncogenic role in SOCE, but rigorous studies will be needed to test this suggestion.

Analysis of mRNA expression in public BC databases (Figure 7A) and of protein levels in BC cell lines (Figure 7C) demonstrated high degree of EHD2 co-expression with caveolin-1/2, the structural elements of caveolae. This was noteworthy since EHD2 is known to regulate the stability of caveolae (Morén et al., 2012; Stoeber et al., 2012). Significantly, EHD2 and CAV1 or CAV2 mRNA overexpression predicted shorter patient survival specifically in the PAM50-defined basal BC (Figure 7B), consistent with the predominant basal (myoepithelial) cell expression of EHD2 in mouse mammary epithelium (Figure 1B and D). Additional analyses of publicly available cell line mRNA data in CCLE (Figure 2C) and of a subset of BC samples analyzed for EHD2 expression (Figure 2A), further reinforce the conclusion that high cytoplasmic EHD2 expression is a feature of BC with basal-like/triple-negative features.

Multi-pronged approaches using shRNA knockdown and CRISPR-Cas9 KO of EHD2 in TNBC cell models together with mouse Ehd2 rescue of EHD2-KO demonstrated that EHD2 is required for tumorigenesis and metastasis. We show that in vitro tumor cell growth under stringent conditions (tumorspheres; Figure 4C) and pro-metastatic traits of cell migration, invasion, and ECM degradation (Figures 4D–E–5B–D) are EHD2-dependent. In vivo, loss of EHD2 markedly impaired the orthotopic TNBC xenograft formation and metastasis (Figure 4F; Figure 5H), and tumor growth was rescued by exogenous mouse Ehd2 (Figure 5H). Notably, intravenous injections demonstrated the inability of EHD2-KO TNBC cells to form lung metastases (Figure 6). Although further studies are needed to fully dissect the steps at which EHD2 is critical in the metastatic process, collectively, our analyses conclusively demonstrate that extranuclear EHD2 overexpression in BC cells represents a key pro-tumorigenic and pro-metastatic adaptation.

Mechanistically, we link the EHD2 overexpression in BC cells to regulation of caveolae, whose stability is known to be controlled by EHD2 (Morén et al., 2012; Stoeber et al., 2012; Morén et al., 2019). This includes the strong EHD2 co-localization with CAV1/2 (Figure 7D), reduction in cell surface caveolae density using TIRF microscopy upon EHD2-KO (Figure 7E), and inhibition of TNBC cell migration upon CAV1-KO (Figure 7G), consistent with the previously documented pro-tumorigenic roles of CAV1 in TNBC (Badana et al., 2016; Zou et al., 2017). However, since our localization analyses show both EHD2 and CAV1 to also localize intracellularly besides at the plasma membrane (Figure 7D), and prior studies have identified pro-oncogenic roles for CAV1 localized in various intracellular locations (Simón et al., 2020), further studies will be needed to determine if the role of EHD2 we define here is exclusively related to regulation of the plasma membrane caveolae or might involve CAV1 in other compartments as well.

Caveolae serve as hubs for signaling (Lamaze et al., 2017). Among these, the SOCE pathway stood out as it is known to regulate multiple tumorigenic and pro-metastatic traits in TNBC (Pani and Singh, 2009; Bohórquez-Hernández et al., 2017), as with EHD2 depletion. Also, EHD2 interacts with Ca²⁺-binding proteins such as Ferlins (Posey et al., 2011) that are involved in Ca²⁺-dependent membrane repair and EHD2 was found to accumulate at sites of membrane repair in skeletal muscle models (Marg et al., 2012; Demonbreun et al., 2016). Indeed, our extensive analyses demonstrate that EHD2 is a major positive regulator of SOCE in TNBC cell models. This includes analyses of fluorescent dye-labeled cells and two distinct agents (thapsigargin or CPA) to release ER Ca²⁺ as stimuli (Figure 8A–B), and independent validation using cytoplasm- or plasma membrane-localized genetic reporters of Ca²⁺ (Figure 8E–F, Figure 8—figure supplement 1A–B). Reciprocally, CRISPR-activation of endogenous EHD2 expression in an EHD2-nonexpressing TNBC cell line upregulated SOCE (Figure 8G) and cell migration (Figure 5G). Complementing these, EHD2-KO reduces the STIM1-Orai1 interaction at the ER-plasma membrane contact sites as measured using fluorescent STIM1 (Figure 9A) and overexpression of STIM1 partially rescues the SOCE and cell migration defects in EHD2-KO TNBC (Figure 9E–F). Consistent with the established role of SOCE in the intracellular Ca²⁺ store refilling (Chung et al., 2017), which then serves as the source of the initial Ca²⁺ release upon appropriate stimuli (Tg or CPA in our studies), loss of EHD2 or CAV1 expression or treatment with SOCE inhibitors led to an impairment of the SOCE as well as the initial Ca²⁺ peak (Figure 8A–E; Figure 8H–I). Reciprocally, CRISPRa upregulation of EHD2 elevated both phases of Ca²⁺ flux (Figure 8G).

Orai1 is a major STIM1-interacting caveolae-resident SOCE channel (Bohórquez-Hernández et al., 2017; Sathish et al., 2012). Indeed, our cell surface biotinylation studies demonstrated that EHD2-KO specifically reduces the cell surface Orai1 levels (Figure 9C). Thus, our findings support a model whereby EHD2-dependent stabilization of cell surface caveolae ensures high cell surface levels of Orai1 to enable robust SOCE in TNBCs, which in turn promotes pro-tumorigenic and pro-metastatic behaviors of tumor cells (Mo and Yang, 2018; Yang et al., 2009). Consistent with this model, EHD2 deficiency reduced the cell surface levels of caveolae-associated ATP-sensitive K⁺ channels (Yang et al., 2018). However, further genetic studies to perturb Orai1 and its family members as well as other potential mediators of SOCE will be necessary to fully establish a causal role of the SOCE pathway in EHD2-dependent oncogenesis.

Finally, consistent with prior studies (Yang et al., 2009), chemical inhibition of SOCE markedly impaired the pro-metastatic traits of EHD2-overexpressing TNBCs, with a smaller impact on EHD2-KO cell lines (Figure 10A) and impaired the TNBC metastatic growth in vivo (Figure 10B). However, since SKF96365 targets additional Ca²⁺ channels besides Orai1 (Ramsey et al., 2006; Ding et al., 2012), further studies using more selective inhibitors together with genetic analyses will be needed.

Together, our studies support the idea that EHD2-overexpressing subsets of TNBC and other BC subtypes may be selectively amenable to SOCE targeting, with EHD2 and CAV1/2 overexpression as predictors of response.

All data generated or analysed during this study are included in the manuscript and supporting file.

1. 1. Abd El-Rehim DM
   2. Ball G
   3. Pinder SE
   4. Rakha E
   5. Paish C
   6. Robertson JFR
   7. Macmillan D
   8. Blamey RW
   9. Ellis IO

   (2005) High-Throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

   International Journal of Cancer 116:340–350.

   https://doi.org/10.1002/ijc.21004

   • PubMed
   • Google Scholar
2. 1. Albers J
   2. Danzer C
   3. Rechsteiner M
   4. Lehmann H
   5. Brandt LP
   6. Hejhal T
   7. Catalano A
   8. Busenhart P
   9. Gonçalves AF
   10. Brandt S
   11. Bode PK
   12. Bode-Lesniewska B
   13. Wild PJ
   14. Frew IJ

   (2015) A versatile modular vector system for rapid combinatorial mammalian genetics

   The Journal of Clinical Investigation 125:1603–1619.

   https://doi.org/10.1172/JCI79743

   • PubMed
   • Google Scholar
3. 1. Badana A
   2. Chintala M
   3. Varikuti G
   4. Pudi N
   5. Kumari S
   6. Kappala VR
   7. Malla RR

   (2016) Lipid raft integrity is required for survival of triple negative breast cancer cells

   Journal of Breast Cancer 19:372–384.

   https://doi.org/10.4048/jbc.2016.19.4.372

   • PubMed
   • Google Scholar
4. 1. Bailey TA
   2. Luan H
   3. Tom E
   4. Bielecki TA
   5. Mohapatra B
   6. Ahmad G
   7. George M
   8. Kelly DL
   9. Natarajan A
   10. Raja SM
   11. Band V
   12. Band H

   (2014) A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cells

   The Journal of Biological Chemistry 289:30443–30458.

   https://doi.org/10.1074/jbc.M114.608992

   • PubMed
   • Google Scholar
5. 1. Band V
   2. Zajchowski D
   3. Swisshelm K
   4. Trask D
   5. Kulesa V
   6. Cohen C
   7. Connolly J
   8. Sager R

   (1990)

   Tumor progression in four mammary epithelial cell lines derived from the same patient

   Cancer Research 50:7351–7357.

   • PubMed
   • Google Scholar
6. 1. Bohórquez-Hernández A
   2. Gratton E
   3. Pacheco J
   4. Asanov A
   5. Vaca L

   (2017) Cholesterol modulates the cellular localization of Orai1 channels and its disposition among membrane domains

   Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids 1862:1481–1490.

   https://doi.org/10.1016/j.bbalip.2017.09.005

   • PubMed
   • Google Scholar
7. 1. Bruen C
   2. Al-Saadi M
   3. Michelson EA
   4. Tanios M
   5. Mendoza-Ayala R
   6. Miller J
   7. Zhang J
   8. Stauderman K
   9. Hebbar S
   10. Hou PC

   (2022) Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial

   Critical Care 26:101.

   https://doi.org/10.1186/s13054-022-03964-8

   • PubMed
   • Google Scholar
8. 1. Chen T-W
   2. Wardill TJ
   3. Sun Y
   4. Pulver SR
   5. Renninger SL
   6. Baohan A
   7. Schreiter ER
   8. Kerr RA
   9. Orger MB
   10. Jayaraman V
   11. Looger LL
   12. Svoboda K
   13. Kim DS

   (2013) Ultrasensitive fluorescent proteins for imaging neuronal activity

   Nature 499:295–300.

   https://doi.org/10.1038/nature12354

   • PubMed
   • Google Scholar
9. 1. Cheung KJ
   2. Ewald AJ

   (2014) Illuminating breast cancer invasion: diverse roles for cell-cell interactions

   Current Opinion in Cell Biology 30:99–111.

   https://doi.org/10.1016/j.ceb.2014.07.003

   • PubMed
   • Google Scholar
10. 1. Chung WY
    2. Jha A
    3. Ahuja M
    4. Muallem S

    (2017) Ca2+ influx at the ER/PM junctions

    Cell Calcium 63:29–32.

    https://doi.org/10.1016/j.ceca.2017.02.009

    • Google Scholar
11. 1. Dai X
    2. Cheng H
    3. Bai Z
    4. Li J

    (2017) Breast cancer cell line classification and its relevance with breast tumor subtyping

    Journal of Cancer 8:3131–3141.

    https://doi.org/10.7150/jca.18457

    • PubMed
    • Google Scholar
12. 1. Demaurex N
    2. Lew DP
    3. Krause KH

    (1992) Cyclopiazonic acid depletes intracellular Ca2+ stores and activates an influx pathway for divalent cations in HL-60 cells

    The Journal of Biological Chemistry 267:2318–2324.

    https://doi.org/10.1016/S0021-9258(18)45880-2

    • PubMed
    • Google Scholar
13. 1. Demonbreun AR
    2. Quattrocelli M
    3. Barefield DY
    4. Allen MV
    5. Swanson KE
    6. McNally EM

    (2016) An actin-dependent annexin complex mediates plasma membrane repair in muscle

    The Journal of Cell Biology 213:705–718.

    https://doi.org/10.1083/jcb.201512022

    • PubMed
    • Google Scholar
14. 1. Ding J
    2. Zhang J-R
    3. Wang Y
    4. Li C-L
    5. Lu D
    6. Guan S-M
    7. Chen J

    (2012) Effects of a non-selective TRPC channel blocker, SKF-96365, on melittin-induced spontaneous persistent nociception and inflammatory pain hypersensitivity

    Neuroscience Bulletin 28:173–181.

    https://doi.org/10.1007/s12264-012-1213-y

    • PubMed
    • Google Scholar
15. 1. Fellmann C
    2. Hoffmann T
    3. Sridhar V
    4. Hopfgartner B
    5. Muhar M
    6. Roth M
    7. Lai DY
    8. Barbosa IAM
    9. Kwon JS
    10. Guan Y
    11. Sinha N
    12. Zuber J

    (2013) An optimized microRNA backbone for effective single-copy RNAi

    Cell Reports 5:1704–1713.

    https://doi.org/10.1016/j.celrep.2013.11.020

    • PubMed
    • Google Scholar
16. 1. George M
    2. Ying G
    3. Rainey MA
    4. Solomon A
    5. Parikh PT
    6. Gao Q
    7. Band V
    8. Band H

    (2007) Shared as well as distinct roles of EHD proteins revealed by biochemical and functional comparisons in mammalian cells and C. elegans

    BMC Cell Biology 8:3.

    https://doi.org/10.1186/1471-2121-8-3

    • PubMed
    • Google Scholar
17. 1. Guan C
    2. Lu C
    3. Xiao M
    4. Chen W

    (2021) Ehd2 overexpression suppresses the proliferation, migration, and invasion in human colon cancer

    Cancer Investigation 39:297–309.

    https://doi.org/10.1080/07357907.2020.1870125

    • PubMed
    • Google Scholar
18. 1. Györffy B
    2. Lanczky A
    3. Eklund AC
    4. Denkert C
    5. Budczies J
    6. Li Q
    7. Szallasi Z

    (2010) An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

    Breast Cancer Research and Treatment 123:725–731.

    https://doi.org/10.1007/s10549-009-0674-9

    • PubMed
    • Google Scholar
19. 1. Hayer A
    2. Stoeber M
    3. Bissig C
    4. Helenius A

    (2010) Biogenesis of caveolae: stepwise assembly of large caveolin and cavin complexes

    Traffic 11:361–382.

    https://doi.org/10.1111/j.1600-0854.2009.01023.x

    • PubMed
    • Google Scholar
20. 1. Jézéquel P
    2. Frénel J-S
    3. Campion L
    4. Guérin-Charbonnel C
    5. Gouraud W
    6. Ricolleau G
    7. Campone M

    (2013) Bc-genexminer 3.0: new mining module computes breast cancer gene expression correlation analyses

    Database 2013:bas060.

    https://doi.org/10.1093/database/bas060

    • PubMed
    • Google Scholar
21. 1. Kim Y
    2. Kim M-H
    3. Jeon S
    4. Kim J
    5. Kim C
    6. Bae JS
    7. Jung CK

    (2017) Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma

    PLOS ONE 12:e0174737.

    https://doi.org/10.1371/journal.pone.0174737

    • PubMed
    • Google Scholar
22. 1. Lamaze C
    2. Tardif N
    3. Dewulf M
    4. Vassilopoulos S
    5. Blouin CM

    (2017) The caveolae dress code: structure and signaling

    Current Opinion in Cell Biology 47:117–125.

    https://doi.org/10.1016/j.ceb.2017.02.014

    • PubMed
    • Google Scholar
23. 1. Lehmann BD
    2. Bauer JA
    3. Chen X
    4. Sanders ME
    5. Chakravarthy AB
    6. Shyr Y
    7. Pietenpol JA

    (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

    The Journal of Clinical Investigation 121:2750–2767.

    https://doi.org/10.1172/JCI45014

    • PubMed
    • Google Scholar
24. 1. Li M
    2. Yang X
    3. Zhang J
    4. Shi H
    5. Hang Q
    6. Huang X
    7. Liu G
    8. Zhu J
    9. He S
    10. Wang H

    (2013) Effects of EHD2 interference on migration of esophageal squamous cell carcinoma

    Medical Oncology 30:396.

    https://doi.org/10.1007/s12032-012-0396-4

    • PubMed
    • Google Scholar
25. 1. Liu J
    2. Ni W
    3. Qu L
    4. Cui X
    5. Lin Z
    6. Liu Q
    7. Zhou H
    8. Ni R

    (2016) Decreased expression of EHD2 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma

    Digestive Diseases and Sciences 61:2554–2567.

    https://doi.org/10.1007/s10620-016-4202-6

    • PubMed
    • Google Scholar
26. 1. Liu C
    2. Liu S
    3. Wang L
    4. Wang Y
    5. Li Y
    6. Cui Y

    (2019) Effect of EH domain containing protein 2 on the biological behavior of clear cell renal cell carcinoma

    Human & Experimental Toxicology 38:927–937.

    https://doi.org/10.1177/0960327119842241

    • PubMed
    • Google Scholar
27. 1. Lu F
    2. Sun J
    3. Sun T
    4. Cheng H
    5. Yang S

    (2018) Fluorescence-based measurements of store-operated ca2+ entry in cancer cells using fluo-4 and confocal live-cell imaging

    Methods in Molecular Biology 1843:63–68.

    https://doi.org/10.1007/978-1-4939-8704-7_5

    • PubMed
    • Google Scholar
28. 1. Luan H
    2. Mohapatra B
    3. Bielecki TA
    4. Mushtaq I
    5. Mirza S
    6. Jennings TA
    7. Clubb RJ
    8. An W
    9. Ahmed D
    10. El-Ansari R
    11. Storck MD
    12. Mishra NK
    13. Guda C
    14. Sheinin YM
    15. Meza JL
    16. Raja S
    17. Rakha EA
    18. Band V
    19. Band H

    (2018) Loss of the nuclear pool of ubiquitin ligase CHIP/Stub1 in breast cancer unleashes the MZF1-cathepsin pro-oncogenic program

    Cancer Research 78:2524–2535.

    https://doi.org/10.1158/0008-5472.CAN-16-2140

    • PubMed
    • Google Scholar
29. 1. Marg A
    2. Schoewel V
    3. Timmel T
    4. Schulze A
    5. Shah C
    6. Daumke O
    7. Spuler S

    (2012) Sarcolemmal repair is a slow process and includes EHD2

    Traffic 13:1286–1294.

    https://doi.org/10.1111/j.1600-0854.2012.01386.x

    • PubMed
    • Google Scholar
30. 1. Matthaeus C
    2. Lian X
    3. Kunz S
    4. Lehmann M
    5. Zhong C
    6. Bernert C
    7. Lahmann I
    8. Müller DN
    9. Gollasch M
    10. Daumke O

    (2019) ENOS-NO-induced small blood vessel relaxation requires EHD2-dependent caveolae stabilization

    PLOS ONE 14:e0223620.

    https://doi.org/10.1371/journal.pone.0223620

    • PubMed
    • Google Scholar
31. 1. Matthaeus C
    2. Lahmann I
    3. Kunz S
    4. Jonas W
    5. Melo AA
    6. Lehmann M
    7. Larsson E
    8. Lundmark R
    9. Kern M
    10. Blüher M
    11. Olschowski H
    12. Kompa J
    13. Brügger B
    14. Müller DN
    15. Haucke V
    16. Schürmann A
    17. Birchmeier C
    18. Daumke O

    (2020) EHD2-mediated restriction of caveolar dynamics regulates cellular fatty acid uptake

    PNAS 117:7471–7481.

    https://doi.org/10.1073/pnas.1918415117

    • PubMed
    • Google Scholar
32. 1. Mo P
    2. Yang S

    (2018) The store-operated calcium channels in cancer metastasis: from cell migration, invasion to metastatic colonization

    Frontiers in Bioscience 23:1241–1256.

    https://doi.org/10.2741/4641

    • PubMed
    • Google Scholar
33. 1. Morén B
    2. Shah C
    3. Howes MT
    4. Schieber NL
    5. McMahon HT
    6. Parton RG
    7. Daumke O
    8. Lundmark R

    (2012) Ehd2 regulates caveolar dynamics via ATP-driven targeting and oligomerization

    Molecular Biology of the Cell 23:1316–1329.

    https://doi.org/10.1091/mbc.E11-09-0787

    • PubMed
    • Google Scholar
34. 1. Morén B
    2. Hansson B
    3. Negoita F
    4. Fryklund C
    5. Lundmark R
    6. Göransson O
    7. Stenkula KG

    (2019) Ehd2 regulates adipocyte function and is enriched at cell surface-associated lipid droplets in primary human adipocytes

    Molecular Biology of the Cell 30:1147–1159.

    https://doi.org/10.1091/mbc.E18-10-0680

    • PubMed
    • Google Scholar
35. 1. Nadeau SA
    2. An W
    3. Mohapatra BC
    4. Mushtaq I
    5. Bielecki TA
    6. Luan H
    7. Zutshi N
    8. Ahmad G
    9. Storck MD
    10. Sanada M
    11. Ogawa S
    12. Band V
    13. Band H

    (2017) Structural determinants of the gain-of-function phenotype of human leukemia-associated mutant Cbl oncogene

    The Journal of Biological Chemistry 292:3666–3682.

    https://doi.org/10.1074/jbc.M116.772723

    • PubMed
    • Google Scholar
36. 1. Naslavsky N
    2. Caplan S

    (2011) EHD proteins: key conductors of endocytic transport

    Trends in Cell Biology 21:122–131.

    https://doi.org/10.1016/j.tcb.2010.10.003

    • PubMed
    • Google Scholar
37. 1. Ong HL
    2. Liu X
    3. Sharma A
    4. Hegde RS
    5. Ambudkar IS

    (2007) Intracellular Ca (2+) release via the ER translocon activates store-operated calcium entry

    Pflugers Archiv 453:797–808.

    https://doi.org/10.1007/s00424-006-0163-5

    • PubMed
    • Google Scholar
38. 1. Pani B
    2. Singh BB

    (2009) Lipid rafts/caveolae as microdomains of calcium signaling

    Cell Calcium 45:625–633.

    https://doi.org/10.1016/j.ceca.2009.02.009

    • PubMed
    • Google Scholar
39. 1. Pekar O
    2. Benjamin S
    3. Weidberg H
    4. Smaldone S
    5. Ramirez F
    6. Horowitz M

    (2012) EHD2 shuttles to the nucleus and represses transcription

    The Biochemical Journal 444:383–394.

    https://doi.org/10.1042/BJ20111268

    • PubMed
    • Google Scholar
40. 1. Peterková L
    2. Kmoníčková E
    3. Ruml T
    4. Rimpelová S

    (2020) Sarco/Endoplasmic reticulum calcium ATPase inhibitors: beyond anticancer perspective

    Journal of Medicinal Chemistry 63:1937–1963.

    https://doi.org/10.1021/acs.jmedchem.9b01509

    • PubMed
    • Google Scholar
41. 1. Posey AD Jr
    2. Pytel P
    3. Gardikiotes K
    4. Demonbreun AR
    5. Rainey M
    6. George M
    7. Band H
    8. McNally EM

    (2011) Endocytic recycling proteins EHD1 and EHD2 interact with fer-1-like-5 (Fer1L5) and mediate myoblast fusion

    The Journal of Biological Chemistry 286:7379–7388.

    https://doi.org/10.1074/jbc.M110.157222

    • PubMed
    • Google Scholar
42. 1. Prakriya M
    2. Feske S
    3. Gwack Y
    4. Srikanth S
    5. Rao A
    6. Hogan PG

    (2006) Orai1 is an essential pore subunit of the CRAC channel

    Nature 443:230–233.

    https://doi.org/10.1038/nature05122

    • PubMed
    • Google Scholar
43. 1. Ramsey IS
    2. Delling M
    3. Clapham DE

    (2006) An introduction to TRP channels

    Annual Review of Physiology 68:619–647.

    https://doi.org/10.1146/annurev.physiol.68.040204.100431

    • PubMed
    • Google Scholar
44. 1. Sathish V
    2. Abcejo AJ
    3. Thompson MA
    4. Sieck GC
    5. Prakash YS
    6. Pabelick CM

    (2012) Caveolin-1 regulation of store-operated Ca (2+) influx in human airway smooth muscle

    The European Respiratory Journal 40:470–478.

    https://doi.org/10.1183/09031936.00090511

    • PubMed
    • Google Scholar
45. 1. Senju Y
    2. Rosenbaum E
    3. Shah C
    4. Hamada-Nakahara S
    5. Itoh Y
    6. Yamamoto K
    7. Hanawa-Suetsugu K
    8. Daumke O
    9. Suetsugu S

    (2015) Phosphorylation of PACSIN2 by protein kinase C triggers the removal of caveolae from the plasma membrane

    Journal of Cell Science 128:2766–2780.

    https://doi.org/10.1242/jcs.167775

    • PubMed
    • Google Scholar
46. 1. Shaw FL
    2. Harrison H
    3. Spence K
    4. Ablett MP
    5. Simões BM
    6. Farnie G
    7. Clarke RB

    (2012) A detailed mammosphere assay protocol for the quantification of breast stem cell activity

    Journal of Mammary Gland Biology and Neoplasia 17:111–117.

    https://doi.org/10.1007/s10911-012-9255-3

    • PubMed
    • Google Scholar
47. 1. Shen W-W
    2. Bièche I
    3. Fuhrmann L
    4. Vacher S
    5. Vincent-Salomon A
    6. Torrino S
    7. Lamaze C

    (2020) Ehd2 is a predictive biomarker of chemotherapy efficacy in triple negative breast carcinoma

    Scientific Reports 10:7998.

    https://doi.org/10.1038/s41598-020-65054-5

    • PubMed
    • Google Scholar
48. 1. Shi Y
    2. Liu X
    3. Sun Y
    4. Wu D
    5. Qiu A
    6. Cheng H
    7. Wu C
    8. Wang X

    (2015) Decreased expression and prognostic role of EHD2 in human breast carcinoma: correlation with E-cadherin

    Journal of Molecular Histology 46:221–231.

    https://doi.org/10.1007/s10735-015-9614-7

    • PubMed
    • Google Scholar
49. 1. Simón L
    2. Campos A
    3. Leyton L
    4. Quest AFG

    (2020) Caveolin-1 function at the plasma membrane and in intracellular compartments in cancer

    Cancer Metastasis Reviews 39:435–453.

    https://doi.org/10.1007/s10555-020-09890-x

    • PubMed
    • Google Scholar
50. 1. Sinha B
    2. Köster D
    3. Ruez R
    4. Gonnord P
    5. Bastiani M
    6. Abankwa D
    7. Stan RV
    8. Butler-Browne G
    9. Vedie B
    10. Johannes L
    11. Morone N
    12. Parton RG
    13. Raposo G
    14. Sens P
    15. Lamaze C
    16. Nassoy P

    (2011) Cells respond to mechanical stress by rapid disassembly of caveolae

    Cell 144:402–413.

    https://doi.org/10.1016/j.cell.2010.12.031

    • PubMed
    • Google Scholar
51. 1. Stoeber M
    2. Stoeck IK
    3. Hänni C
    4. Bleck CKE
    5. Balistreri G
    6. Helenius A

    (2012) Oligomers of the ATPase EHD2 confine caveolae to the plasma membrane through association with actin

    The EMBO Journal 31:2350–2364.

    https://doi.org/10.1038/emboj.2012.98

    • PubMed
    • Google Scholar
52. 1. Torrino S
    2. Shen W-W
    3. Blouin CM
    4. Mani SK
    5. Viaris de Lesegno C
    6. Bost P
    7. Grassart A
    8. Köster D
    9. Valades-Cruz CA
    10. Chambon V
    11. Johannes L
    12. Pierobon P
    13. Soumelis V
    14. Coirault C
    15. Vassilopoulos S
    16. Lamaze C

    (2018) Ehd2 is a mechanotransducer connecting caveolae dynamics with gene transcription

    The Journal of Cell Biology 217:4092–4105.

    https://doi.org/10.1083/jcb.201801122

    • PubMed
    • Google Scholar
53. 1. Tsai F-C
    2. Seki A
    3. Yang HW
    4. Hayer A
    5. Carrasco S
    6. Malmersjö S
    7. Meyer T

    (2014) A polarized Ca2+, diacylglycerol and STIM1 signalling system regulates directed cell migration

    Nature Cell Biology 16:133–144.

    https://doi.org/10.1038/ncb2906

    • PubMed
    • Google Scholar
54. 1. Wu MM
    2. Buchanan J
    3. Luik RM
    4. Lewis RS

    (2006) Ca2+ store depletion causes STIM1 to accumulate in ER regions closely associated with the plasma membrane

    The Journal of Cell Biology 174:803–813.

    https://doi.org/10.1083/jcb.200604014

    • PubMed
    • Google Scholar
55. 1. Yang S
    2. Zhang JJ
    3. Huang XY

    (2009) Orai1 and STIM1 are critical for breast tumor cell migration and metastasis

    Cancer Cell 15:124–134.

    https://doi.org/10.1016/j.ccr.2008.12.019

    • PubMed
    • Google Scholar
56. 1. Yang X
    2. Ren H
    3. Yao L
    4. Chen X
    5. He A

    (2015) Role of EHD2 in migration and invasion of human breast cancer cells

    Tumour Biology 36:3717–3726.

    https://doi.org/10.1007/s13277-014-3011-9

    • PubMed
    • Google Scholar
57. 1. Yang HQ
    2. Jana K
    3. Rindler MJ
    4. Coetzee WA

    (2018) The trafficking protein, EHD2, positively regulates cardiac sarcolemmal KATP channel surface expression: role in cardioprotection

    FASEB Journal 32:1613–1625.

    https://doi.org/10.1096/fj.201700027R

    • PubMed
    • Google Scholar
58. 1. Zhang Z
    2. Chen J
    3. Huo X
    4. Zong G
    5. Huang K
    6. Cheng M
    7. Sun L
    8. Yue X
    9. Bian E
    10. Zhao B

    (2021) Identification of a mesenchymal-related signature associated with clinical prognosis in glioma

    Aging 13:12431–12455.

    https://doi.org/10.18632/aging.202886

    • PubMed
    • Google Scholar
59. 1. Zhao X
    2. Malhotra GK
    3. Lele SM
    4. Lele MS
    5. West WW
    6. Eudy JD
    7. Band H
    8. Band V

    (2010) Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate

    PNAS 107:14146–14151.

    https://doi.org/10.1073/pnas.1009030107

    • PubMed
    • Google Scholar
60. 1. Zou M
    2. Li Y
    3. Xia S
    4. Chu Q
    5. Xiao X
    6. Qiu H
    7. Chen Y
    8. Zheng Z
    9. Liu F
    10. Zhuang L
    11. Yu S

    (2017) Knockdown of caveolin-1 sensitizes human basal-like triple-negative breast cancer cells to radiation

    Cellular Physiology and Biochemistry 44:778–791.

    https://doi.org/10.1159/000485291

    • PubMed
    • Google Scholar

Author details

1. Haitao Luan

   Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States

   Contribution

   Conceptualization, Data curation, Formal analysis, Validation, Visualization, Methodology, Writing – original draft, Writing – review and editing

   Contributed equally with

   Timothy A Bielecki and Bhopal C Mohapatra

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-9831-167X

2. Timothy A Bielecki

   Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States

   Contribution

   Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing, Conceptualization

   Contributed equally with

   Haitao Luan and Bhopal C Mohapatra

   Competing interests

   No competing interests declared

3. Bhopal C Mohapatra

   1. Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States
   2. Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, United States

   Contribution

   Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – review and editing, Conceptualization

   Contributed equally with

   Haitao Luan and Timothy A Bielecki

   Competing interests

   No competing interests declared

4. Namista Islam

   1. Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States
   2. Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States

   Contribution

   Data curation, Formal analysis

   Competing interests

   No competing interests declared

5. Insha Mushtaq

   1. Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States
   2. Department of Pathology & Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, United States

   Contribution

   Data curation, Formal analysis

   Competing interests

   No competing interests declared

6. Aaqib M Bhat

   1. Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States
   2. Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States

   Contribution

   Data curation, Formal analysis

   Competing interests

   No competing interests declared

7. Sameer Mirza

   Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States

   Contribution

   Data curation, Formal analysis

   Competing interests

   No competing interests declared

8. Sukanya Chakraborty

   1. Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States
   2. Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States

   Contribution

   Data curation, Formal analysis

   Competing interests

   No competing interests declared

9. Mohsin Raza

   Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States

   Contribution

   Data curation, Formal analysis

   Competing interests

   No competing interests declared

10. Matthew D Storck

    Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States

    Contribution

    Resources, Project administration

    Competing interests

    No competing interests declared

11. Michael S Toss

    Department of Histopathology, Nottingham University Hospital NHS Trust, City Hospital Campus, Nottingham, United Kingdom

    Contribution

    Data curation, Formal analysis

    Competing interests

    No competing interests declared

12. Jane L Meza

    1. Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, United States
    2. Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, United States

    Contribution

    Formal analysis, Validation

    Competing interests

    No competing interests declared

13. Wallace B Thoreson

    Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, United States

    Contribution

    Data curation, Formal analysis

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0001-7104-042X

14. Donald W Coulter

    1. Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, United States
    2. Department of Pediatrics, University of Nebraska Medical Center, Omaha, United States

    Contribution

    Formal analysis

    Competing interests

    No competing interests declared

15. Emad A Rakha

    Department of Histopathology, Nottingham University Hospital NHS Trust, City Hospital Campus, Nottingham, United Kingdom

    Contribution

    Formal analysis, Validation

    Competing interests

    No competing interests declared

16. Vimla Band

    1. Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States
    2. Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, United States

    Contribution

    Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Methodology, Writing – review and editing

    For correspondence

    vband@unmc.edu

    Competing interests

    received funding from Nimbus Therapeutics for an unrelated project

    "This ORCID iD identifies the author of this article:" 0000-0003-2014-7205

17. Hamid Band

    1. Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States
    2. Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States
    3. Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, United States
    4. Department of Pathology & Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, United States

    Contribution

    Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing

    For correspondence

    hband@unmc.edu

    Competing interests

    received funding from Nimbus Therapeutics for an unrelated project

    "This ORCID iD identifies the author of this article:" 0000-0002-4996-9002

• 1,207

  views

• 210

  downloads

• 3

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.